Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich type of cancer will see the most significant advancements in treatment due to the Cancer Moonshot initiative by the end of 2025?
Brain cancer • 25%
Breast cancer • 25%
Lung cancer • 25%
Other • 25%
Peer-reviewed publications and official health statistics reports
Biden Allocates $150 Million for Cancer Moonshot Initiative, Highlights ARPA-H Role in New Orleans
Aug 13, 2024, 08:39 PM
President Joe Biden is dedicating $150 million in federal funding to his 'Cancer Moonshot' initiative, aiming to significantly reduce cancer fatalities in the United States. The funding will be directed towards developing advanced technologies for more effective tumor-removal surgeries, with the goal of cutting U.S. cancer deaths by 50% over the next 25 years. This initiative, launched during the Obama administration and re-launched in 2022, is a personal mission for Biden, whose son Beau died of brain cancer in 2015. The funding will support eight research centers, including Tulane University, to pioneer new methods in precision cancer surgery. The administration recently awarded nearly $9 million to improve access to cancer screenings and follow-up treatments in underserved communities. Biden's efforts are part of a broader strategy to mobilize the entire country in the fight against cancer. The Advanced Research Projects Agency for Health (ARPA-H) is playing a key role in fast-tracking these advancements. Biden and the First Lady announced this funding during their visit to New Orleans.
View original story
Breast cancer • 25%
Lung cancer • 25%
Prostate cancer • 25%
Other • 25%
NTRK gene fusion cancers • 25%
RET fusion-positive cancers • 25%
Both equally • 25%
Neither • 25%
Lung Cancer • 25%
Breast Cancer • 25%
Melanoma • 25%
Other • 25%
Technology development for surgeons • 25%
Cancer screenings • 25%
Follow-up treatments • 25%
Other • 25%
Breast Cancer • 25%
Lung Cancer • 25%
Prostate Cancer • 25%
Colorectal Cancer • 25%
Lymphoma • 25%
Breast Cancer • 25%
Lung Cancer • 25%
Other • 25%
Rectal cancer • 25%
Breast cancer • 25%
Lung cancer • 25%
Other • 25%
Breast Cancer • 25%
Lung Cancer • 25%
Prostate Cancer • 25%
Colorectal Cancer • 25%
Lung cancer • 25%
Breast cancer • 25%
Colorectal cancer • 25%
Other • 25%
Lung Cancer • 25%
Prostate Cancer • 25%
Breast Cancer • 25%
Other • 25%
Lung Cancer • 25%
Breast Cancer • 25%
Colon Cancer • 25%
Other • 25%
Breast Cancer • 25%
Lung Cancer • 25%
Prostate Cancer • 25%
Other • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Tumor-removal technologies • 25%
Other • 25%
Cancer treatment in underserved communities • 25%
Cancer screening and early detection • 25%